CD4 T cell-mediated cardiac allograft rejection requires donor but not host MHC class II

被引:148
|
作者
Pietra, BA
Wiseman, A
Bolwerk, A
Rizeq, M
Gill, RG
机构
[1] Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Dept Med, Denver, CO 80262 USA
[2] Childrens Hosp, Div Cardiol, Denver, CO 80218 USA
[3] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Nephrol, Denver, CO 80262 USA
[4] Univ Colorado, Hlth Sci Ctr, Vet Affairs Med Ctr, Dept Pathol, Denver, CO 80262 USA
来源
JOURNAL OF CLINICAL INVESTIGATION | 2000年 / 106卷 / 08期
关键词
D O I
10.1172/JCI10467
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Numerous studies indicate that CD4 T cells are required for acute cardiac allograft rejection. However, the precise role for CD4 T cells in this response has remained ambiguous owing to the multipotential properties of this T-cell subpopulation. In the current study, we demonstrate the capacity of CD4 T cells to serve as direct effector cells of cardiac allograft rejection. We show that CD4 T cells are both necessary and sufficient for acute graft rejection, as indicated by adoptive transfer experiments in immune-deficient SCID and rag1(-/-) recipients. We have analyzed the contribution of direct (donor MHC class II restricted) and indirect (host MHC class II restricted) antigen recognition in CD4-mediated rejection. Acute CD4 T cell-mediated rejection required MHC class II expression by the allograft, indicating the importance of direct graft recognition. In contrast, reciprocal experiments indicate that CD4 T cells can acutely reject allogeneic cardiac allografts established in rag1(-/-) hosts that were also MHC class II deficient. This latter result indicates that indirect presentation of donor antigens by host MHC class II is not required for acute CD4-mediated rejection. Taken together, these results indicate that CD4 T cells can serve as effector cells for primary acute cardiac allograft rejection, predominantly via direct donor antigen recognition and independent of indirect reactivity.
引用
收藏
页码:1003 / 1010
页数:8
相关论文
共 50 条
  • [41] Anti-Donor HLA Class I Antibodies: Pathways to Endothelial Cell Activation and Cell-Mediated Allograft Rejection
    Naemi, Fatmah M. A.
    Carter, Vaughan
    Kirby, John A.
    Ali, Simi
    [J]. TRANSPLANTATION, 2013, 96 (03) : 258 - 266
  • [42] Analysis of the CD40 and CD28 T cell costimulatory pathways in allograft rejection mediated by CD4 and CD8 T cell subsets
    Bingaman, AW
    Ha, J
    Waitze, SR
    Tucker-Burden, C
    Pearson, TC
    Larsen, CP
    [J]. TRANSPLANTATION, 1999, 67 (07) : S262 - S262
  • [43] THE INTERACTION OF CD4 AND CLASS-II MHC PROTEINS
    BROGDON, J
    DOYLE, C
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 77 - 77
  • [44] THE INTERACTION OF CD4 AND CLASS-II MHC PROTEINS
    BROGDON, J
    DOYLE, C
    [J]. FASEB JOURNAL, 1992, 6 (05): : A1709 - A1709
  • [45] THE INTERACTION OF CD4 AND CLASS-II MHC PROTEINS
    BROGDON, J
    DOYLE, C
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 340 - 340
  • [46] CONTROL OF MEMORY CD4 T-CELL ACTIVATION - MHC CLASS-II MOLECULES ON APCS AND CD4 LIGATION INHIBIT MEMORY BUT NOT NAIVE CD4 T-CELLS
    FARBER, DL
    LUQMAN, M
    ACUTO, O
    BOTTOMLY, K
    [J]. IMMUNITY, 1995, 2 (03) : 249 - 259
  • [47] REQUIREMENT FOR PEPTIDE IN ALLOREACTIVE CD4(+) T-CELL RECOGNITION OF CLASS-II MHC MOLECULES
    WEBER, DA
    TERRELL, NK
    ZHANG, Y
    STRINDBERG, G
    MARTIN, J
    RUDENSKY, A
    BRAUNSTEIN, NS
    [J]. JOURNAL OF IMMUNOLOGY, 1995, 154 (10): : 5153 - 5164
  • [48] Peptide-MHC Class II Complex Stability Governs CD4 T Cell Clonal Selection
    Baumgartner, Christina K.
    Ferrante, Andrea
    Nagaoka, Mika
    Gorski, Jack
    Malherbe, Laurent P.
    [J]. JOURNAL OF IMMUNOLOGY, 2010, 184 (02): : 573 - 581
  • [49] Arteriogenesis is hampered in the absence of CD4(+) T lymphocytes after CD4 depletion or in MHC class II-/- mice
    Van Weel, V
    Toes, RE
    Sipkens, J
    Van Hinsbergh, VW
    Van Bockel, JH
    Quax, P
    [J]. CIRCULATION, 2004, 110 (17) : 71 - 71
  • [50] T cell MHC class II molecules downregulate CD4(+) T cell response following LAG-3 binding
    Triebel, F
    Huard, B
    [J]. HUMAN IMMUNOLOGY, 1996, 47 (1-2) : O371 - O371